POTENTIAL EFFECTS OF BOVINE COLOSTRUM IN PREVENTION OF NECROTIZING ENTEROCOLITIS: A REVIEW
Authors:
- Aleksandra PrzybylskaAPAleksandra Przybylska
- Julia CiechanowiczJCJulia Ciechanowicz
- Stanisław CiechanowiczSCStanisław Ciechanowicz
- Julia DuraJDJulia Dura
- Marika GutowskaMGMarika Gutowska
- Piotr KupidłowskiPKPiotr Kupidłowski
- Agata NowackaANAgata Nowacka
- Adrianna PerzanowskaAPAdrianna Perzanowska
- Zuzanna TomaszewskaZTZuzanna Tomaszewska
- Anna ZielińskaAZAnna Zielińska
Open Access
- 5 September 2025
- journal article
- review article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(47))
Abstract
Objectives: Necrotizing enterocolitis is a critical gastrointestinal disorder predominantly affecting neonates. Bovine colostrum is a nutrient-dense first secretion from cows postpartum. Bovine colostrum is abundant in immunoglobulins, antimicrobial peptides as well as growth factors, making it a promising candidate for nutritional intervention for necrotizing enterocolitis. This review aims to critically assess the existing preclinical and clinical evidence on the efficacy of bovine colostrum supplementation in reducing the incidence and severity of necrotizing enterocolitis in neonatal populations. Methods: A literature search was conducted using PubMed and Scopus databases. Relevant animal trials and human randomized controlled trials evaluating the impact of bovine colostrum on necrotizing enterocolitis incidence and severity were analysed. Key findings: Preclinical studies in neonatal piglet models consistently demonstrate that bovine colostrum reduced the incidence and severity of necrotizing enterocolitis compared to infant formula, with mechanisms involving enhanced gut barrier integrity, microbiota modulation and reduction in inflammation. Bovine colostrum outcomes were often comparable or superior to human donor milk. However, recent randomised controlled trials in preterm human infants have not shown a statistically significant reductions in necrotizing enterocolitis incidences with bovine colostrum supplementation, possibly due to differences in product processing, dosage and open-label study designs. Conclusions: Despite promising outcomes in zootechnical models, current clinical evidence does not confirm efficacy of bovine colostrum in necrotizing enterocolitis prevention in human neonates. Further high-quality, standardized, double-blinded clinical trials are needed to clarify its potential in infant care.Keywords
This publication has 34 references indexed in Scilit:
- Prevention Strategies and Management of Necrotizing EnterocolitisCurrent Treatment Options in Pediatrics, 2024
- Bovine colostrum to supplement the first feeding of very preterm infants: The PreColos randomized controlled trialClinical Nutrition, 2023
- Bovine colostrum as a fortifier to human milk in very preterm infants – A randomized controlled trial (FortiColos)Clinical Nutrition, 2023
- Programmed and environmental determinants driving neonatal mucosal immune developmentImmunity, 2023
- Contemporary Outcomes for Infants with Necrotizing Enterocolitis—A Systematic ReviewThe Journal of Pediatrics, 2020
- Formula versus donor breast milk for feeding preterm or low birth weight infantsCochrane Database of Systematic Reviews, 2019
- Necrotizing Enterocolitis and Neurodevelopmental OutcomeClinics in Perinatology, 2018
- Human Milk Fortification with Bovine Colostrum Is Superior to Formula‐Based Fortifiers to Prevent Gut Dysfunction, Necrotizing Enterocolitis, and Systemic Infection in Preterm PigsJournal of Parenteral and Enteral Nutrition, 2018
- Association between duration of intravenous antibiotic administration and early-life microbiota development in late-preterm infantsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2018
- Toll-Like Receptor–Mediated Intestinal Inflammatory Imbalance in the Pathogenesis of Necrotizing EnterocolitisCellular and Molecular Gastroenterology and Hepatology, 2018